MeiraGTx Holdings PLC (NAS:MGTX)
$ 6.73 0.31 (4.83%) Market Cap: 519.45 Mil Enterprise Value: 483.11 Mil PE Ratio: 0 PB Ratio: 5.19 GF Score: 41/100

MeiraGTx Holdings PLC at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript

Apr 24, 2023 / 06:30PM GMT
Release Date Price: $5.4 (-4.76%)
Geulah Livshits
Chardan Capital Markets, LLC - Analyst

Good afternoon. It's now my pleasure to introduce Dr. Zandy Forbes, President and Chief Executive Officer from MeiraGTx. So the format for this session is roughly 25-minute fireside chat. If you have any questions in the session, feel free to enter them into the question box.

Questions & Answers

Geulah Livshits
Chardan Capital Markets, LLC - Analyst

So Zandy, thanks again for joining us. To start off, can you give us an overview of Meira's manufacturing and CMC capabilities and discuss how they fit into the company's broader strategy?

Zandy Forbes
MeiraGTx Holdings plc - President & CEO

So we have extremely broad and very flexible and scalable manufacturing capabilities. When we set the company up as a technology development as well as clinical gene therapy company, it was very important to us that we were able to manufacture in-house, and this has, in fact, enabled us to move forward with our clinical pipeline in a timely fashion. But in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot